Answers are grounded in this paper and cite their sources.
Objective To assess the long-term impact of chemotherapy exposure on pregnancy outcomes in women treated during childhood, adolescence, or young adulthood (CAYA). Data sources MEDLINE, Embase, and the Cochrane Library from 1990 to April 2023. Methods All studies reporting on pregnancy outcomes in adult females who had received chemotherapy or chemoradiotherapy during CAYA (<25 years) were included. The primary outcome was the live-birth rate. One of the secondary outcomes was preterm birth. For each outcome, a random-effect frequentist network meta-analysis (NMA) was carried out to estimate the risk ratios with 95 % confidence intervals. Sensitivity analyses were conducted by excluding studies at high risk of bias and the leave-one-out method. Results Eight studies were included in the meta-analysis on live-birth rates: 3,997 females became pregnant, leading to 2,878 live births. The NMA showed moderate heterogeneity or inconsistency (τ 2 = 0.012, I 2 = 58 % [11 %; 80 %]) and did not show any significant impact of treatments on live-birth rate. Six studies reported a total of 125 preterm births out of 1,976 started pregnancies and were included in the NMA (τ 2 = 0.07, I 2 = 19 % [0 %; 62 %]). Chemoradiotherapy was significantly associated with a higher risk of preterm birth when compared to the control group (3.44 [1.94; 6.09]) and the chemotherapy group (1.93 [1.19; 3.15]). Chemotherapy alone was associated with a statistically higher risk of preterm birth compared to the control group (1.78 [1.01; 3.13]). Conclusion Although live-birth rate was similar in pregnant women with a history of CAYA chemotherapy or chemoradiotherapy, preterm birth was significantly increased.
No takes yet. Share an insight, caveat, or question.
Fraison et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: